Oktober 2005. Volume 3, No. 3
Transcription
Oktober 2005. Volume 3, No. 3
Drug and Food Gontrol BADAN Newsletter RI N"ttqril Ag"r"y "f Volume 3 No.3, October 2005 The 3o edition ofNADFC Newsletter published in medio October 2005 is strive to give the readers on some imporTant news, public warnings and regular activities of NADFC in the third quafter of 2005. One of the ls that the important neyvs NADFC has been successfu//y aciomplished the WHO assessmenf of National Vaccine Regulatory System on 15-19 August 2005. The investigation team of NADFC suppofted by N QCLD F fo u nd trad iti o n al med ici ne s wh ich we re mi xed with chemical subsfances. In order to protect the people's health, the NADFC then published public warnings which were also disseminated to all regional offices of NADFC throughout Indonesia. UNITAR supporfs a limited number of country-based projects which meant to strengthen capacities and facilitate development of a national GHS implementation strategy. These projects are executed by UNITAR with funding from the government of Switze rl a ndand Eu rope a n Com m i ssi on. Hearing with House of Parliament members, dlscussed about the importance of having regulations on food and drug control. The 9'' ASEAN Food Conference 2005 was held on 8-10 August 2005 in Bidakara Hotel, Jakarla. The Conference discussed currentissues on Ethnic and traditional Food, Food Technology Education, Food Processing Engineering, Food Safety, and Nutrition and Health. The Conference was officially opened by the Minister of Research and Technology. Regulation Government of Republic of lndonesia no. 21 2005 regarding Genetically Modified Product was signed by President Republic of lndonesia on 19 May 2005 in Jakarta. Thankyou. / Public Worning : ARMA S/N GAIVG SAN LANGS/NG AYU Product Confoining Drug C hem ico I Subs/onces Sl BUTRAM I N E HYDROCHLORTDE UNITAR ... .......... 1 Copocity Building Progrctmme in /ndoneslo ............ The WHO Assessrnenl of The Notronctl Voccine ReguloforySyslem in lndonesio Public Worning : lllegol Producf Confctining Drug Chemicol Substonce SILDENAFIL CITRATE 2 ..... 2 ...... 2 Governmenl Regulotion No.21 yeor 2005 on Biosofely of Geneficolly Modified Product ...... 4 Ihe 9'' ASFAN Food Conference 2005 . . .. . .. 4 NADFC's Vision ond Mlsslon lmplementotion on Achieve Sofely ond quolily s/ondords Phormoceulicol I Producls olrtrtta -l Nr.r.-1. Octohcr' )005 .... .... .. .. 4 l-l ffi V supports a limited number of country based projects to strengihen capacities and facilitate development of a national GHS implementation strategy, in the context of the UNITAR Globally Harmonized System of Classification and Agency for each of the four sectors of transport, industrial production, agriculture and consumer products as well as the industry and civil society partners. The lead sectoral agency for transport is Ministry of Transportation, lndustrial production is Ministry of lndustry, Agricultural is Ministry of Labelling- Agriculture, Consumer Product is Ministry of Trade. eginning in 1 June 2005 until 31 May 2007-, UNITAR of Programm'e, Chemicals (GHS) Capacity Building with funding from the Government of Switzerland and the European Commission. The overallgoal of the national GHS projects is to strengthen capacities to implement the GHS by the year 2008. lt thus contributes both to the protection of human health and the environment from dangerous chemicals, and to facilitating the trade in chemicals between countries and their trading partners. Illore specifically, national projects aim at achieving the following objectives for the four sectors affected by the GHS. A National GHS lmplementation Committee (or an existing committee) comprising representatives of ministries and stakeholder groups for the purpose of advising matters of project implementation and drafting laws/regulations will be established in each partner country. NADFC is designated as a Project Coordinating For the duration of the project, NADFC as the Coordinating Agency will convene meetings of the GHS lmplementation Committee; provide secretariat support to the project; and coordinate participation of national representatives at GHSrelevant international meetings. The project is divided into three phases as follows : 1. Phase 1 : Preparation of a GHS situation/Gap analysis and Comprehensibility Testing (approximately 6 2. 3. months) 2 : Targeted GHS Capacity Development (approximately I 2 months) Phase 3 : Development of a Sirategic plan (Road map) Phase for National GHS lmplementation by 2008 (approximately 6 months).- The programms of the visit are as follows: r/ ln medio of August 2005, the National Agency of Drug and Food Control (NADFC) as a National Regulatory Authority (NRA) has been visited by the WHO review team in the context of the programme on assessment of national vaccine regulatory system in lndonesia. Mr. R. Dobbelaer from NCL Belgium as a team leader. The previous assessment were conducted in 200'l for pharmaceutical and biologycal product and 2003 for biologycal product. The objectives of these programms are to assess the national vaccine regulatory system against the WHO published indicators and to develop and submit an updated institutional development plan. The main objective was to review the regulation and control of vaccines conducted by NADFC and review relevant functions or areas that may involve other institutions such as the National lmmunization Programme (NEPI) against the WHO published NRA indicators. This activity included identifying specific technical inputs that may be needed by the national vaccine regulatory system to meet the NRA critical indicators required by the WHO prequalification. Iitltrnta.l No..l. Ot rohu' 1005 r/ r/ r/ i r,i Review of the functions during the 2003 review and achievements reported (NADFC and NEPI) at central and district level NADFC and NEPI Regulatory inspections in a Regional NADFC Office Review of Regulatory inspections, Clinical evaluation of safety and efficacy and Post-marketing surveillance Visit to vaccine manufacturer to document GMP enforcement Visit to immunization and disease surveillance programme Presentation of the findings and discussions of the recommendations technical inputs needed, timelines, funding sources, and mechanisms for monitoring progress and impact and identify training needs for each relevant functions and indicators.- The other objective is to find and formulate list of gaps on technical inputs needed, timelines, funding sources, and mechanisms for monitoring progress and impact and training needs for each relevant functions and indicators. Most of the indicators assessment on NADFC have been improved compared to 2003 result.- !q. \ trl g ,l Jamu Sehat Pria "Seki", Samiaji, Capsul/TR.003202221 (fictiv e number) Jamu "Pasihot" Andalan Pria Perkasa, capsul/TR.003202301 (fi ctive number) Tablet "Cobra Laut" TR.003200621 (fictive number) 10 11 12 13 14 15 Tablet "Pas-Tipas", Obat Kuai dan Tahan Lama/ without registraiion number Obat Kuat dan Tahan Lama "Busur Perkasa", Capsul/TR.89351 8901 (fictive number) Obat Kuat dan Tahan Lama "X-mas" (siated as Klimax), Capsul/TR.048277 503 (fi ctive number) Obat Kuat dan Tahan Lama "Pegasus Kuda Terbang", Capsul/TR.024341 57 2 (fictive number) Obat Kuat "Spider", Capsul/TR.99357 58412 (fictive number) Obat penambah Vitalitas Pria "Scorpion", capsul/TR.022341563 (fictive number) Penambah vitalitas dan Gairah Sex "Vi-Gra", capsul/TR.022341 563 (fictive number) Obat Kuat Pria Dewasa "Pastigra, capsul/TR.04258336 1 (fictive number) Jamu Kuat dan Tahan Lama "Kuda Mas", capsul/TR.0243511 47 2 (fictive number) Jamu Kuat Perkasa "Spontan On, capsuliTR.023 4357 32 (fictive number) Obat Kuai Andalan Pria Dewasa "Bali-Bali", capsul/TR.023541 832 (fictive number) Obat Kuat Andalan Pria Merk "Bali-Bali", capsul/TR.2336457'108 (fictive number) Iitlttntt,-l ,Vo.-1. OL tohcr' )00 j Kopja Aneka Sari, Jawa Tengah, lndonesia PJ. Khasiat Makasar lndonesia PJ. Tawon Api Makasar Banyumas Drs. Naspan, Cilacap Sildenafil Citrate Not registered / illegal Sildenafil Citrate Not registered / illegal Sildenafil Citrate Not registered / illegal Sildenafil Citrate Not registered / illegal PJ. Bangun Sukses Perkasa, Denpasar PJ. Great Herb, lndonesia PJ. Alam Sehat, Jabar Sildenafil Citrate Not registered / illegal Sildenafil Citrate Not registered / illegal Sildenafil Citrate Not registered / illegal PJ. Sinar Makmur, Madura PJ. Sinar Makmur, Madura Hema Care Sildenafil Citrate Not registered / illegal Sildenafil Citrate Not registered / illegal Sildenafil Citrate Not registered / illegal Hema Care Sildenafil Citrate Not registered PJ. MakmurAbadi, Jatim PJ. Sinar Wahyu, Sumbar PJ. Madura Sakti Sildenafil Citrate Not registered / illegal Sildenafil Citrate Not registered / illegal Sildenafil Citrate Not registered / illegal PT. Jaya Makmur, Sildenafil Citrate Not registered / illegal Bandung t i illegal Drug and Food Gontrol Newsletter Advisors:Drs. H. Sampurno, MBA; Mawanvati Djamaluddin, Dipl. Pharm; Chief Editor:E.D. Syarief Syamsuri, MSc; Secretary Editor : Dra. Yunida Nugrahanti; Editorial Staff : Drs. Rahardjo, Dra. Tutut Sumartini, Dra. Lia Marliana, MKes, Dra. Diah Tritunggariani, MKes, Yanni Parmawati, SSi; Distribution : Jaeni, Delima Address : Bureau of lnternational Cooperation, The National Agency of Drug and Food Control Republic of lndonesia, Jalan Percetakan Negara No. 23 Jakarta 10560 lndonesia email : [email protected], website :www.pom.go.id Volume 3 No.3, October 2005 4